Savara, Inc.
SVRABiotechnology
$4.95−1.39%As of Oct 29vs prior close
- Market cap
- $1B
- P/E (TTM)
- –
- From 52W high
- −28.67%
- EPS (LTM)
- -$0.58
- Revenue (YE20)
- $257K
Nomior Score
43
Steady ProfileBottom 36% of the scored universe
Growth61
Quality38
Value35
Momentum60
Resilience41
Growth
−10.47%revenue a year over 4 fiscal years
YE16 $400KYE20 $257K
Connections
Revenue to profitYE20
The operating loss was 19183% of revenue.
Who owns it
2funds